PTH and hyperuricemia: The use of cinacalcet, a calcimimetic drug that can reduce PTH levels, in these animals prevented the ABCG2 reduction and urate accumulation, suggesting a potential therapeutic approach to mitigate SHPT-induced hyperuricemia.